Value of serum TSGF,AFP,VEGF in curative effect evaluation of primary hepatic carcinoma
10.3969/j.issn.1673-4130.2016.03.016
- VernacularTitle:血清 TSGF 、A FP 、VEGF 在原发性肝癌治疗疗效评价中的价值
- Author:
Suling MENG
- Publication Type:Journal Article
- Keywords:
primary hepatic carcinoma;
tumor specific growth factor;
alpha-fetoprotein;
vascular endothelial cell growth factor
- From:
International Journal of Laboratory Medicine
2016;(3):329-330
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the evaluation of tumor specific growth factor (TSGF) ,alpha‐fetoprotein (AFP) and vascular endothelial cell growth factor(VEGF) levels in therapeutic effect of primary hepatic carcinoma (PHC) .Methods Serum TSGF , AFP and VEGF levels were detected on 1 d before treatment ,4 ,28 d after treatment in 75 patients with PHC .The relation between serum VEGF with AFP on 1 d before treatment was analyzed .Results The levels of serum TSGF ,AFP and VEGF on 4 ,28 d after treatment in 75 cases of PHC were significantly lower than those on 1 d before treatment ,the difference was statistically significant (P< 0 .05) .The VEGF level had no statistical difference between the patients with AFP ≥ 400 ng/mL and the patients with AFP <400 ng/mL(P> 0 .05) .Conclusion TSGF ,AFP and VEGF can serve as the indicators for evaluating PHC prognosis .
